Missouri earns a D, ranking 35th of 51 states in overall health. About 6.2 million people live here, and their health story is a study in institutional ambition colliding with structural neglect. The metro corridors of St. Louis and Kansas City drive most of what's working. The Bootheel and the Ozarks absorb most of what isn't.
The central contradiction: Missouri pulls in $186 million in NIH funding and hosts nearly 18,400 active clinical trials, ranking top 10 nationally on both. Yet nearly one in three adults does nothing physical in their leisure time, one in five smokes, and the state's death rate runs above the national average. You can have world-class researchers and a largely sedentary population at the same time. Missouri is the proof.
There are genuine strengths. The uninsured rate of 10.0 percent sits below the national average. Medicare acceptance ranks top 10 nationally. Community ties appear stronger here than in most states, with loneliness and social isolation running below national norms. But those advantages haven't been enough to overcome elevated smoking, obesity, disability, and a county-level mortality gap that puts Missouri's best and worst places in entirely different health universes.
The numbers on the ReportCard aren't subtle. Obesity at 38.9 percent, above national. Smoking at 19.1 percent, well above national. Physical inactivity at 31.9 percent, worse than 45 states. Put these three together and you don't need a predictive model. The trajectory writes itself.
The prescription data confirms what the behavior data predicts. Atorvastatin, the cholesterol drug, leads the state with over 3.3 million claims. Amlodipine and Lisinopril, both heart and blood pressure drugs, follow close behind. Furosemide, a diuretic used in managing heart failure, logged 1.4 million claims on its own. Missouri isn't treating cardiovascular disease at the margins. It's managing an epidemic at scale.
Smoking is where it starts. At 19.1 percent, Missouri is worse than 44 states. Rhode Island has an adult smoking rate of just 11 percent. Missouri is nearly double that. Smoking feeds directly into COPD, which runs well above national rates here, accelerates cardiovascular damage, and drives the chronic lung conditions that produce disability and limit physical activity. Every cigarette is also a future prescription claim.
Physical inactivity sits at 31.9 percent. One in three adults does nothing physical in their leisure time. In Washington, D.C., that number is 15.1 percent. That population moves twice as much, and fares better on multiple health measures despite ranking 25th overall. The connection isn't complicated.
The uninsured rate of 10.0 percent is below the national average of 11.4, which matters. Coverage gives people a pathway into the system. But median household income at $58,829, worse than 41 states, means coverage doesn't always translate into care. In the Bootheel, the numbers run far worse, and that gap compounds over a lifetime.
Missouri's sharpest divergence from national norms isn't smoking or obesity. It's disability. More than one in three Missouri adults reports some form of disability. The national rate is about one in four. That gap, showing up across cognitive, mobility, and hearing disability simultaneously, doesn't happen by accident. It's what decades of chronic disease, poverty, and limited healthcare access produce when left unaddressed.
Each category tells the same story at a different angle. Cognitive disability affects 19.4 percent of Missouri adults, versus 16.1 percent nationally. Mobility disability runs above national rates. So does hearing disability. When you see elevation across every disability type at once, the explanation isn't demographic bad luck.
Dental health makes it concrete. Nearly one in five Missouri adults 65 and older has lost all their teeth, compared to roughly one in six nationally. That's not cosmetic. Tooth loss marks a lifetime of missed dental care, which tracks directly with income and insurance gaps. Depression affects more than one in four adults here. Arthritis runs above national rates. The body is carrying more than the country as a whole.
Two measures run the other direction. Missouri adults report lower rates of loneliness and lower rates of lacking social and emotional support than the national average. Only 20.3 percent report lacking social support, versus nearly 24 percent nationally. In a state with deep community ties, multigenerational families, and small-town networks, that cohesion is real. It just hasn't translated into the health behaviors that would move the needle. Missouri has the community. The community hasn't gotten people off the couch or out of cigarettes.
The SocialRadarChart shows Missouri near national norms on housing cost burden, but state-level averages hide the rural reality. In the Bootheel and the Ozarks, housing is cheap because wages are low. And low wages constrain every health-adjacent choice: food quality, transportation to a clinic, the ability to take time off for a doctor's visit, the capacity to fill a prescription when the checking account is empty.
Income inequality, at an index of 4.39, means the distance between Missouri's economic winners and losers is wide. St. Charles County households earn close to $99,000. Pemiscot County households earn around $42,000. Same state. Different world. The children in those two counties have dramatically different lifespans ahead of them, and the mortality data confirms it.
High school graduation runs at roughly 91.4 percent, above many peer states. Unemployment is officially low. The educational attainment is real. But in communities where the economic opportunity to match it doesn't exist, a diploma doesn't automatically produce the stable income that protects health over a lifetime.
Missouri has 96,388 total healthcare providers, with 33,413 enrolled in CMS. Of those, 95.1 percent accept Medicare, placing Missouri in the top 10 nationally. That's a genuine strength. Rhode Island, the country's top-ranked state overall, has a Medicare acceptance rate of just 91.8 percent. Missouri does better on this specific measure than the healthiest state in America.
Telehealth is a different story. Only 11.2 percent of CMS-enrolled providers offer telehealth, worse than 39 states. Massachusetts, ranked second nationally, has 27.8 percent of its CMS providers offering telehealth. In a state with substantial rural geography and widespread primary care shortages, telehealth is exactly the lever Missouri should be pulling. It isn't. So where do people go when they can't reach a doctor in person?
They end up in shortage areas. Missouri has 337 primary care shortage areas. Mental health shortage areas number 367. Dental shortage areas total 320. These aren't fringe deficits. They confirm that unmet healthcare need in Missouri is structural and widespread. The state leans heavily on nurse practitioners, at nearly 11,000 in practice, and mental health counselors, to fill provider gaps. The fill isn't complete.
The facility inventory reflects the disease burden. Missouri has 151 dialysis facilities. That count isn't coincidence. With elevated obesity, cardiovascular disease, and diabetes rates, kidney failure follows downstream. Missouri has the dialysis centers because the population demands them.
Emergency room visits run at 670.5 per 1,000 residents. That's a heavy load, and in a state with 337 primary care shortage areas, it makes sense. When you can't see a primary care doctor, you go to the emergency department. It's not a failure of personal responsibility. It's a rational response to a system where primary care isn't accessible. The ER becomes the default entry point, the most expensive and least efficient one available.
Patients who leave the hospital and return quickly often lack the follow-up support to recover at home: a timely specialist visit, medication management, a home health check-in. Missouri has 123 home health agencies and 129 hospice providers, exactly the kinds of post-acute resources that reduce readmissions when deployed effectively. Whether they're reaching the patients who need them most is a separate question entirely.
A median household income of $58,829, worse than 41 states, is the financial backdrop for everything in Missouri's health story. The gap from the national median is about $7,000 per year. That sounds manageable until you price out what it buys: prescriptions filled, copays covered, dental appointments not skipped, fresh food instead of fast food. The uninsured rate of 10.0 percent is better than average. But coverage without income still leaves people making impossible trade-offs.
The RankedBarList tells the scale of Missouri's drug burden: 74 million total claims, $11.2 billion in total spending. The top drugs read as a clinical directory of what's gone uncontrolled. Atorvastatin for cholesterol. Amlodipine and Lisinopril for blood pressure and heart failure. Metformin for diabetes. Gabapentin for nerve pain, often the downstream consequence of uncontrolled diabetes. Furosemide, a diuretic for heart failure, logged 1.4 million claims on its own. These aren't medications for people managing minor conditions. They're the pharmacological signature of a state managing obesity, cardiovascular disease, and diabetes at enormous scale.
The average procedure carries a cost of $65.36 and a charge of $322.18, roughly a five-to-one ratio. Uninsured patients face the charge price, not the negotiated cost. That gap illustrates exactly how the system works against those who already have the least. The dominant insurers are Aetna with nearly 39,600 in-network providers, followed by Medicare, Cigna, UMR, and UnitedHealthcare.
Pharmaceutical companies paid Missouri providers $51.3 million across nearly 305,000 individual transactions, from 794 companies to 21,305 providers. The average payment was $168. But averages obscure the structure of the money. The PharmaDonutChart shows how it actually breaks down.
Royalties and licensing fees total $15.5 million across just 262 payments, averaging roughly $59,000 per transaction. These are large sums going to a small number of researchers, reflecting the commercial value of Missouri's academic research pipeline, primarily at Washington University and the University of Missouri. Speaker fees and faculty compensation add $10.2 million. Consulting fees total $9.3 million. Concentrated money flowing to a relatively small number of high-value relationships.
Then there's food and beverage: 280,658 individual payments totaling $7.9 million. Each transaction averages about $28. It's the lunch at the CME event, the dinner at the conference, the coffee before the pitch. Small amounts individually. But nearly 281,000 pharma-to-provider touchpoints per year is the ambient background noise of industry presence in Missouri clinical practice. The big money goes to a handful of researchers. The small money reaches nearly everyone else.
There are currently 65 providers excluded from federal healthcare programs in Missouri, a rate of 0.7 per 1,000 providers. The historical total is far higher at 1,164, but the number that matters for patient safety is who's operating now. Sixty-five active exclusions across 96,000 providers is a contained problem.
Medicare opt-outs tell a different story, and a more encouraging one. 595 providers have opted out entirely, a rate of 6.2 per 1,000 CMS-enrolled providers, placing Missouri among the lowest in the country. Vermont ranks 11th overall in health outcomes but has an opt-out rate of 16.9 per 1,000, nearly three times Missouri's. Providers staying in Medicare matters enormously for the state's millions of Medicare-dependent patients. The 95.1 percent Medicare acceptance rate reinforces the same picture: Missouri's healthcare workforce is broadly committed to the public insurance system, even as the state's population health outcomes lag far behind.
The research numbers are the sharpest surprise in Missouri's entire health profile. The state receives $186 million in NIH funding, placing it in the top 10 nationally. Wyoming ranks 20th overall, far above Missouri on population health outcomes, but receives less than $440,000 in total NIH funding. Missouri's research investment is more than 400 times larger. At $30 per resident, Missouri's NIH funding per capita also lands in the top 10. Idaho ranks 15th overall and is doing considerably better on population health, yet receives just $1 per capita. Missouri outspends it thirty-to-one per resident.
The 311 NIH grants and 18,374 active clinical trials, top 15 nationally, are anchored by Washington University in St. Louis, one of the country's leading academic medical centers, with major programs in oncology, neurology, genomics, and cardiovascular medicine. The University of Missouri contributes biomedical research capacity. Saint Louis University adds clinical trial infrastructure. The knowledge production is real and substantial.
So why doesn't it show up in the outcomes? Missouri's institutions are generating findings about cardiovascular disease, diabetes, and neurological conditions at a level few states can match. The population those institutions serve, especially in the rural counties, isn't benefiting from that knowledge anywhere near the rate the research output would predict. The knowledge is being created. The pipeline from laboratory to the Bootheel doesn't exist.
The county gap in Missouri is among the most severe in the country. The CountyDotPlot makes it visible: Nodaway County in the northwest has a death rate of 5,076 per 100,000. Pemiscot County in the Bootheel has a death rate of 22,326. That's a 4.4-to-1 mortality gap within a single state. Pemiscot's rate doesn't quite reach the territory of Buffalo County, South Dakota, the single worst county nationally at 46,418. But it's in the same category of regional health crisis.
St. Charles County and Platte County, both in the Kansas City suburban orbit, have death rates below 6,500 and household incomes approaching $100,000. These counties look like success stories. Ripley County in the Ozarks has a death rate of 17,870 and median income around $43,000. Iron County sits at 16,913. Dunklin County in the Bootheel reaches 16,343. The pattern is geographic and economic: distance from metropolitan health infrastructure correlates almost perfectly with mortality.
Missouri's healthiest counties tend to have universities or sit within reach of Kansas City or St. Louis. Nodaway has Northwest Missouri State University. Holt County and Osage County are in stable agricultural Missouri with relatively anchored economies. The worst counties are isolated, economically depleted, and far from everything the state's metro health systems have built. The gap isn't closing.
The defining tension in Missouri's health story is the distance between what the state's research institutions know and what its rural counties experience. Washington University in St. Louis runs trials that change how cardiovascular disease is treated worldwide. Pemiscot County, five hours to the south, has a death rate that would place it among the most distressed communities in the developed world. These two facts coexist in the same state. That coexistence is the indictment.
Missouri keeps its providers in the Medicare system at rates that outperform Rhode Island, the country's healthiest state. Its NIH research funding per capita beats Idaho and Wyoming, both of which rank above Missouri in overall health outcomes despite attracting a fraction of the state's federal research investment. These aren't footnotes. They're evidence that Missouri's institutions are functional, that its healthcare workforce is committed, and that the problem isn't systemic collapse. It's geography and economics: the people who most need what the system can offer are the least able to reach it.
Missouri's grade is a D. That won't change until the research and clinical capacity concentrated in St. Louis and Kansas City finds a way to reach Pemiscot, Ripley, Iron, and Dunklin. The state has the institutions, the providers, and the knowledge. What it doesn't have is a plan for the last five hours of the drive. Everything else is commentary.